ArticleClinical pharmacokinetics2020

Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach.

Alexander Solms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.